Anti-COVID19 prophylactic paper published in October 2021 already downloaded over 3600 times
Today Nanomerics is pleased to announce that the publication (SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may...
top of page
Recent News
- Nov 11, 2021
Wellcome Board Appointment
Nanomerics CSO Ijeoma Uchegbu has been appointed to the board of Wellcome Ijeoma Uchegbu appointed to Wellcome board | News | Wellcome
- May 23, 2021
Nanomerics announces ocular progress with new patents and two key publications
Nanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced the Company had been granted patent...
- May 12, 2021
Nanomerics CSO Prof IF Uchegbu elected to Academy of Medical Sciences
Today the UK Academy of Medical Sciences announced the election of 50 new biomedical health scientists to its influential fellowship;...
- Mar 23, 2021
Double Milestone Payment Strengthens Nanomerics' Balance Sheet and Enables Clinical Programs
Nanomerics Ltd., a world leader in molecular engineered delivery technologies, today announced that the Company had received its first...
- Dec 12, 2020
Nanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replication
Nanomerics Molecular Mask MM019 inhibits SARS-CoV-2 replication in ex-vivo human airway epithelial air liquid interface cultures. Today...
- Aug 3, 2020
Nanomerics receives pIND guidance from the US FDA for NM134
Today Nanomerics received supportive pIND guidance from the US FDA on the development of its asset - NM134. NM134 is indicated for the...
bottom of page